BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34266595)

  • 1. Lewy bodies in the olfactory system and the hypothalamus.
    Cersosimo MG; Benarroch EE; Raina GB
    Handb Clin Neurol; 2021; 182():235-244. PubMed ID: 34266595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies.
    Cersosimo MG
    Cell Tissue Res; 2018 Jul; 373(1):233-243. PubMed ID: 29196808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-synuclein pathology in the olfactory pathways of dementia patients.
    Hubbard PS; Esiri MM; Reading M; McShane R; Nagy Z
    J Anat; 2007 Jul; 211(1):117-24. PubMed ID: 17553102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
    Acta Neuropathol; 2010 Jun; 119(6):723-35. PubMed ID: 20383714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lewy body pathology involves the olfactory cells in Parkinson's disease and related disorders.
    Saito Y; Shioya A; Sano T; Sumikura H; Murata M; Murayama S
    Mov Disord; 2016 Jan; 31(1):135-8. PubMed ID: 26748832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lewy Body Disease Primate Model with α-Synuclein Propagation from the Olfactory Bulb.
    Sawamura M; Onoe H; Tsukada H; Isa K; Yamakado H; Okuda S; Ikuno M; Hatanaka Y; Murayama S; Uemura N; Isa T; Takahashi R
    Mov Disord; 2022 Oct; 37(10):2033-2044. PubMed ID: 35989519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of α-synuclein is regulated in a neuronal cell type-dependent manner.
    Taguchi K; Watanabe Y; Tsujimura A; Tanaka M
    Anat Sci Int; 2019 Jan; 94(1):11-22. PubMed ID: 30362073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The center of olfactory bulb-seeded α-synucleinopathy is the limbic system and the ensuing pathology is higher in male than in female mice.
    Mason DM; Wang Y; Bhatia TN; Miner KM; Trbojevic SA; Stolz JF; Luk KC; Leak RK
    Brain Pathol; 2019 Nov; 29(6):741-770. PubMed ID: 30854742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multi-Organ Distribution of Alpha-Synuclein Pathology in Dementia with Lewy Bodies].
    Wakabayashi K; Miki Y
    Brain Nerve; 2018 May; 70(5):489-500. PubMed ID: 29760287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential insular cortex subregional vulnerability to α-synuclein pathology in Parkinson's disease and dementia with Lewy bodies.
    Fathy YY; Jonker AJ; Oudejans E; de Jong FJJ; van Dam AW; Rozemuller AJM; van de Berg WDJ
    Neuropathol Appl Neurobiol; 2019 Apr; 45(3):262-277. PubMed ID: 29797340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein and Lewy pathology in Parkinson's disease.
    Kalia LV; Kalia SK
    Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathologic analysis of Lewy-related α-synucleinopathy in olfactory mucosa.
    Funabe S; Takao M; Saito Y; Hatsuta H; Sugiyama M; Ito S; Kanemaru K; Sawabe M; Arai T; Mochizuki H; Hattori N; Murayama S
    Neuropathology; 2013 Feb; 33(1):47-58. PubMed ID: 22672612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.
    Stuendl A; Kunadt M; Kruse N; Bartels C; Moebius W; Danzer KM; Mollenhauer B; Schneider A
    Brain; 2016 Feb; 139(Pt 2):481-94. PubMed ID: 26647156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIGAR inclusion pathology is specific for Lewy body diseases.
    López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
    Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
    Jellinger KA
    Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
    Schell H; Hasegawa T; Neumann M; Kahle PJ
    Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Spillantini MG; Goedert M
    Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
    Beach TG; White CL; Hladik CL; Sabbagh MN; Connor DJ; Shill HA; Sue LI; Sasse J; Bachalakuri J; Henry-Watson J; Akiyama H; Adler CH;
    Acta Neuropathol; 2009 Feb; 117(2):169-74. PubMed ID: 18982334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.